Kevin P Maresca

6PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 13, 2026
AI-Powered Lesion-Level Tumor Growth Inhibition Modeling Improves Model Stability and Prognostic Association With PFS.

|Jun 04, 2025
Machine Learning to Automatically Differentiate Hypertrophic Cardiomyopathy, Cardiac Light Chain, and Cardiac Transthyretin Amyloidosis: A Multicenter CMR Study.

Lukas Damian Weberling, Andreas Ochs, Mitchel Benovoy

|May 14, 2025
A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies.

Keith Abayasiriwardana, Lei Wu, Hanane Laklai

|Mar 21, 2025
18F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors.

Anand Giddabasappa, Ziyue Karen Jiang, Bing Yang

|Jun 28, 2023
Characterization of a Novel M4 PAM PET Radioligand [11C]PF06885190 in Nonhuman Primates (NHP).

Sangram Nag, Ryosuke Arakawa, Zhisheng Jia

|Jun 18, 2021
Preclinical Evaluation of 89Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy.

Kevin P Maresca, Jianqing Chen, Divya Mathur

Pageof 1

Frequent Collaborators

2 joint publications

Lisa Manzuk

2 joint publications

Anand Giddabasappa

2 joint publications

Edward Cabral

2 joint publications

Sripad Ram